MiR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer

Molecular Cancer

Volumn 13, Issue 1, 2014, Pages

  Yu, Jingshuang ^a   Xie, Furong ^a   Bao, Xin ^a   Chen, Wantao ^a   Xu, Qin ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

EMT; Metastasis; MicroRNA

Indexed keywords

MICRORNA; MICRORNA 300; RNA; TRANSCRIPTION FACTOR TWIST; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; LUCIFERASE; NUCLEAR PROTEIN; SMALL INTERFERING RNA; TWIST1 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER PATIENT; CANCER THERAPY; CARCINOMA CELL; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE TARGETING; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUCIFERASE ASSAY; LUNG METASTASIS; MCF 7 CELL LINE; METASTASIS; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR INVASION; ANIMAL; ANTAGONISTS AND INHIBITORS; BREAST TUMOR; DRUG SCREENING; EPITHELIUM CELL; FEMALE; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; HEAD AND NECK TUMOR; LUNG TUMOR; METABOLISM; MOUSE; NUDE MOUSE; PATHOLOGY; REPORTER GENE; SECONDARY; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; ANIMALS; BREAST NEOPLASMS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; EPIGENESIS, GENETIC; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HEAD AND NECK NEOPLASMS; HUMANS; LUCIFERASES; LUNG NEOPLASMS; MICE; MICE, NUDE; MICRORNAS; NEOPLASM INVASIVENESS; NUCLEAR PROTEINS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TWIST TRANSCRIPTION FACTOR; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84901947376     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-13-121     Document Type: Article

References (34)

1. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233. 10.1016/j.cell.2009.01.002, 3794896, 19167326.
2. Tili E, Michaille JJ, Croce CM. MicroRNAs play a central role in molecular dysfunctions linking inflammation with cancer. Immunol Rev 2013, 253:167-184. 10.1111/imr.12050, 23550646.
3. D'Amato NC, Howe EN, Richer JK. MicroRNA regulation of epithelial plasticity in cancer. Cancer Lett 2013, 341:46-55. 10.1016/j.canlet.2012.11.054, 23228634.
4. Gregory PA, Bracken CP, Bert AG, Goodall GJ. MicroRNAs as regulators of epithelial-mesenchymal transition. Cell Cycle 2008, 7:3112-3118. 10.4161/cc.7.20.6851, 18927505.
5. Yao D, Dai C, Peng S. Mechanism of the mesenchymal-epithelial transition and its relationship with metastatic tumor formation. Mol Cancer Res 2011, 9:1608-1620. 10.1158/1541-7786.MCR-10-0568, 21840933.
6. de Krijger I, Mekenkamp LJ, Punt CJ, Nagtegaal ID. MicroRNAs in colorectal cancer metastasis. J Pathol 2011, 224:438-447. 10.1002/path.2922, 21706478.
7. Miettinen PJ, Ebner R, Lopez AR, Derynck R. TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. J Cell Biol 1994, 127:2021-2036. 10.1083/jcb.127.6.2021, 2120317, 7806579.
8. Kitamura K, Seike M, Okano T, Matsuda K, Miyanaga A, Mizutani H, Noro R, Minegishi Y, Kubota K, Gemma A. MiR-134/487b/655 cluster regulates TGF-β-induced epithelial-mesenchymal transition and drug resistance to gefitinib by targeting MAGI2 in lung adenocarcinoma cells. Mol Cancer Ther 2013, Epub ahead of print.
9. Gheldof A, Berx G. Cadherins and epithelial-to-mesenchymal transition. Prog Mol Biol Transl Sci 2013, 116:317-336.
10. Korpal M, Lee ES, Hu G, Kang Y. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem 2008, 283:14910-14914. 10.1074/jbc.C800074200, 3258899, 18411277.
11. Korpal M, Kang Y. The emerging role of miR-200 family of microRNAs in epithelial-mesenchymal transition and cancer metastasis. RNA Biol 2008, 5:115-119. 10.4161/rna.5.3.6558, 3532896, 19182522.
12. Xu Q, Sun Q, Zhang J, Yu J, Chen W, Zhang Z. Downregulation of miR-153 contributes to epithelial-mesenchymal transition and tumor metastasis in human epithelial cancer. Carcinogenesis 2013, 34:539-549. 10.1093/carcin/bgs374, 23188671.
13. Park SM, Gaur AB, Lengyel E, Peter ME. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 2008, 22:894-907. 10.1101/gad.1640608, 2279201, 18381893.
14. Zhang JP, Zeng C, Xu L, Gong J, Fang JH, Zhuang SM. MicroRNA-148a suppresses the epithelial-mesenchymal transition and metastasis of hepatoma cells by targeting Met/Snail signaling. Oncogene 2013, Epub ahead of print.
15. Riihimäki M, Thomsen H, Hemminki A, Sundquist K, Hemminki K. Comparison of survival of patients with metastases from known versus unknown primaries: survival in metastatic cancer. BMC Cancer 2013, 13:36. 10.1186/1471-2407-13-36, 3565900, 23356713.
16. Pecina-Slaus N, Cicvara-Pecina T, Kafka A. Epithelial-to-mesenchymal transition: possible role in meningiomas. Front Biosci (Elite Ed) 2012, 4:889-896.
17. Guarino M, Rubino B, Ballabio G. The role of epithelial-mesenchymal transition in cancer pathology. Pathology 2007, 39:305-318. 10.1080/00313020701329914, 17558857.
18. Yan X, Liang H, Deng T, Zhu K, Zhang S, Wang N, Jiang X, Wang X, Liu R, Zen K, Zhang CY, Ba Y, Chen X. The identification of novel targets of miR-16 and characterization of their biological functions in cancer cells. Mol Cancer 2013, 12:92. 10.1186/1476-4598-12-92, 3751425, 23941513.
19. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, Savagner P, Gitelman I, Richardson A, Weinberg RA. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004, 117:927-939. 10.1016/j.cell.2004.06.006, 15210113.
20. da Silva SD, Alaoui-Jamali MA, Soares FA, Carraro DM, Brentani HP, Hier M, Rogatto SR, Kowalski LP. TWIST1 is a molecular marker for a poor prognosis in oral cancer and represents a potential therapeutic target. Cancer 2013, Epub ahead of print.
21. Yuen HF, Chan YP, Wong ML, Kwok WK, Chan KK, Lee PY, Srivastava G, Law SY, Wong YC, Wang X, Chan KW. Upregulation of Twist in oesophageal squamous cell carcinoma is associated with neoplastic transformation and distant metastasis. J Clin Pathol 2007, 60:510-514. 1994533, 16822877.
22. Kwok WK, Ling MT, Lee TW, Lau TC, Zhou C, Zhang X, Chua CW, Chan KW, Chan FL, Glackin C, Wong YC, Wang X. Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target. Cancer Res 2005, 65:5153-5162. 10.1158/0008-5472.CAN-04-3785, 15958559.
23. Kyo S, Sakaguchi J, Ohno S, Mizumoto Y, Maida Y, Hashimoto M, Nakamura M, Takakura M, Nakajima M, Masutomi K, Inoue M. High Twist expression is involved in infiltrative endometrial cancer and affects patient survival. Hum Pathol 2006, 37:431-438. 10.1016/j.humpath.2005.12.021, 16564917.
24. Song X, Wang J, Zheng T, Song R, Liang Y, Bhatta N, Yin D, Pan S, Liu J, Jiang H, Liu L. LBH589 Inhibits proliferation and metastasis of hepatocellular carcinoma via inhibition of gankyrin/STAT3/Akt pathway. Mol Cancer 2013, 12:114. 10.1186/1476-4598-12-114, 3853770, 24093956.
25. Reka AK, Kurapati H, Narala VR, Bommer G, Chen J, Standiford TJ, Keshamouni VG. Peroxisome proliferator-activated receptor-gamma activation inhibits tumor metastasis by antagonizing Smad3-mediated epithelial-mesenchymal transition. Mol Cancer Ther 2010, 9:3221-3232. 10.1158/1535-7163.MCT-10-0570, 3044476, 21159608.
26. Xu F, Wei Z, Zhang Z, Ge J, Xie P. Differential expression of microRNA clusters in bladder transitional cell carcinoma. Chinese-German J Clin Oncol 2013, 12:285-289.
27. Pang JC, Kwok WK, Chen Z, Ng HK. Oncogenic role of microRNAs in brain tumors. Acta Neuropathol 2009, 117:599-611. 10.1007/s00401-009-0525-0, 19343354.
28. Tetzlaff MT, Liu A, Xu X, Master SR, Baldwin DA, Tobias JW, Livolsi VA, Baloch ZW. Differential expression of miRNAs in papillary thyroid carcinoma compared to multinodular goiter using formalin fixed paraffin embedded tissues. Endocr Pathol 2007, 18:163-173. 10.1007/s12022-007-0023-7, 18058265.
29. Kim SY, Chu KC, Lee HR, Lee KS, Carey TE. Establishment and characterization of nine new head and neck cancer cell lines. Acta Otolaryngol 1997, 117:775-784. 10.3109/00016489709113477, 9349880.
30. Leung T, Rajendran R, Singh S, Garva R, Krstic-Demonacos M, Demonacos C. Cytochrome P450 2E1 (CYP2E1) regulates the response to oxidative stress and migration of breast cancer cells. Breast Cancer Res 2013, 15:R107. 10.1186/bcr3574, 3979157, 24207099.
31. Brabletz T, Jung A, Reu S, Porzner M, Hlubek F, Kunz-Schughart LA, Knuechel R, Kirchner T. Variable β-catenin expression in colorectal cancer indicates a tumor progression driven by the tumor environment. Proc Natl Acad Sci U S A 2001, 98:10356-10361. 10.1073/pnas.171610498, 56965, 11526241.
32. Xu Q, Liu X, Chen W, Zhang Z. Inhibiting adenoid cystic carcinoma cells growth and metastasis by blocking the expression of ADAM 10 using RNA interference. J Transl Med 2010, 8:136. 10.1186/1479-5876-8-136, 3017514, 21171968.
33. Mazière P, Enright AJ. Prediction of microRNA targets. Drug Discov Today 2007, 12:452-458. 10.1016/j.drudis.2007.04.002, 17532529.
34. Yang X, Wei LL, Tang C, Slack R, Mueller S, Lippman ME. Overexpression of KAI1 suppresses in vitro invasiveness and in vivo metastasis in breast cancer cells. Cancer Res 2001, 61:5284-5288.